NABRIVA THERAPEUTICS PLC

CUSIP: G63637105 Class: SHS

FIRST MANHATTAN CO. LLC.'s Holding History (CIK: 0000728083)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 12,500 Value ($000) $6 Avg Close — Range —
Q2 2020
Shares 12,500 Value ($000) $8 Avg Close — Range —
Q1 2020
Shares 12,500 Value ($000) $7 Avg Close — Range —